0001104659-23-082566.txt : 20230720 0001104659-23-082566.hdr.sgml : 20230720 20230720085605 ACCESSION NUMBER: 0001104659-23-082566 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230714 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230720 DATE AS OF CHANGE: 20230720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 231098242 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 8-K 1 tm2321618d1_8k.htm FORM 8-K
0001737953 false 0001737953 2023-07-14 2023-07-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  July 14, 2023

 

 

 

REPLIMUNE GROUP, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38596   82-2082553
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification Number)

 

500 Unicorn Park

Suite 303

Woburn, MA 01801

(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code: (781) 222-9600

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  Name of each exchange on which registered
Common Stock, par value $0.001 per share   REPL   The Nasdaq Stock Market LLC
(Nasdaq Global Select Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 14, 2023, Sander Slootweg, a member of the Board of Directors (the “Board”) of Replimune Group, Inc. (the “Company”), notified the Board that he will not stand for reelection at the Company’s 2023 annual meeting of stockholders (the “Annual Meeting”), and therefore his service as a director of the Company will end at the conclusion of the Annual Meeting. Mr. Slootweg’s decision to not stand for reelection at the Annual Meeting was not the result of any dispute or disagreement with the Company, its management, the Board, or any matter relating to the Company’s operations, policies or practices.

 

Item 7.01 Regulation FD Disclosure.

 

On July 20, 2023, the Company issued a press release regarding Mr. Slootweg’s notification that he will not stand for reelection at the Annual Meeting, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this Item 7.01 and the accompanying Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
     
99.1   News Release dated July 20, 2023
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  REPLIMUNE GROUP, INC.
     
Date: July 20, 2023 By: /s/ Philip Astley-Sparke
    Philip Astley-Sparke
    Chief Executive Officer

 

 

EX-99.1 2 tm2321618d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Replimune Announces Sander Slootweg will Depart from its Board of Directors

 

WOBURN, Mass., July 20, 2023 – Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, today announced Sander Slootweg, founder and managing partner at Forbion, will not seek to be reappointed as a non-executive director at the end of his current term at the company’s upcoming annual general meeting.

 

“It has been a pleasure working with Sander since the inception of Replimune several years ago,” said Philip Astley-Sparke, CEO of Replimune. “We are grateful for Sander’s sage advice, expertise and Forbion’s support of Replimune, and the other directors and members of our executive team join me in wishing Sander continued success.”

 

“I am incredibly proud of being part of the board, and especially in what Replimune has accomplished since the company’s founding,” said Sander Slootweg, founder and managing partner at Forbion. “It was our belief from the start that tumor-directed oncolytic immunotherapy had immense potential to benefit patients in a variety of cancers, and I believe the company is well positioned to fulfill its promise.”

 

About Replimune

 

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of novel tumor-directed oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform has a unique dual local and systemic mechanism of action consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. This MOA is expected to be synergistic with most established and experimental cancer treatment modalities, and, with an attractive safety profile the RPx platform has the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

 

 

 

 

Forward Looking Statements

 

This press release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the design and advancement of our clinical trials, the timing and sufficiency of our clinical trial outcomes to support potential approval of any of our product candidates, our goals to develop and commercialize our product candidates, patient enrollments in our existing and planned clinical trials and the timing thereof, and other statements identified by words such as “could,” “expects,” “intends,” “may,” “plans,” “potential,” “should,” “will,” “would,” or similar expressions and the negatives of those terms. Forward-looking statements are not promises or guarantees of future performance, and are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in such forward-looking statements. These factors include risks related to our limited operating history, our ability to generate positive clinical trial results for our product candidates, the costs and timing of operating our in-house manufacturing facility, the timing and scope of regulatory approvals, changes in laws and regulations to which we are subject, competitive pressures, our ability to identify additional product candidates, political and global macro factors including the impact of the coronavirus as a global pandemic and related public health issues, and other risks as may be detailed from time to time in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q and other reports we file with the Securities and Exchange Commission. Our actual results could differ materially from the results described in or implied by such forward-looking statements. Forward-looking statements speak only as of the date hereof, and, except as required by law, we undertake no obligation to update or revise these forward-looking statements.

 

Investor Inquiries

Chris Brinzey

Westwicke, an ICR Company

339.970.2843

chris.brinzey@westwicke.com

 

Media Inquiries

Arleen Goldenberg

Replimune

917.548.1582

media@replimune.com

 

 

 

 

EX-101.SCH 3 repl-20230714.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 repl-20230714_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 repl-20230714_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jul. 14, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 14, 2023
Entity File Number 001-38596
Entity Registrant Name REPLIMUNE GROUP, INC.
Entity Central Index Key 0001737953
Entity Tax Identification Number 82-2082553
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 500 Unicorn Park
Entity Address, Address Line Two Suite 303
Entity Address, City or Town Woburn
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01801
City Area Code 781
Local Phone Number 222-9600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol REPL
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
XML 7 tm2321618d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001737953 2023-07-14 2023-07-14 iso4217:USD shares iso4217:USD shares 0001737953 false 8-K 2023-07-14 REPLIMUNE GROUP, INC. DE 001-38596 82-2082553 500 Unicorn Park Suite 303 Woburn MA 01801 781 222-9600 false false false false Common Stock, par value $0.001 per share REPL NASDAQ true true EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://replimune.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2321618d1_8k.htm repl-20230714.xsd repl-20230714_lab.xml repl-20230714_pre.xml tm2321618d1_ex99-1.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2321618d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "tm2321618d1_8k.htm" ] }, "labelLink": { "local": [ "repl-20230714_lab.xml" ] }, "presentationLink": { "local": [ "repl-20230714_pre.xml" ] }, "schema": { "local": [ "repl-20230714.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "repl", "nsuri": "http://replimune.com/20230714", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2321618d1_8k.htm", "contextRef": "AsOf2023-07-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://replimune.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2321618d1_8k.htm", "contextRef": "AsOf2023-07-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://replimune.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001104659-23-082566-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-082566-xbrl.zip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end